Clopidogrel
Indication
Treatment of unstable angina and NSTEMI (NICE CG94 and CG172)
Unstable angina and NSTEMI: early management (NICE CG94)
Myocardial infarction: cardiac rehabilitation and prevention of further MI (NICE CG172)
MHRA Drug Safety Update - Clopidogrel: risk of acquired haemophilia
Green
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Cardiovascular system
Background
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: